|
|
||||||||
Modulates
4
7 Integrin-Mediated Lymphocyte Adhesion to Mucosal Addressin Cell Adhesion Molecule-1 and Fibronectin1




* Department of Immunology, Centro de Investigaciones Biológicas, and
Department of Immunology and Oncology, Centro Nacional de Biotecnología, Madrid, Spain; and
Millenium Pharmaceuticals, Inc., Cambridge, MA 02139
| Abstract |
|---|
|
|
|---|
4
7 and its ligand, mucosal addressin cell
adhesion molecule-1, on high endothelial venules represents a key
adhesion event during lymphocyte homing to secondary lymphoid tissue.
Stromal cell-derived factor-1
(SDF-1
) is a chemokine that
attracts T and B lymphocytes and has been hypothesized to be involved
in lymphocyte homing. In this work we show that
4
7-mediated adhesion of CD4+
T lymphocytes and the RPMI 8866 cell line to mucosal addressin cell
adhesion molecule-1 was up-regulated by SDF-1
in both static
adhesion and cell detachment under shear stress assays. Both naive and
memory phenotype CD4+ T cells were targets of
SDF-1
-triggered increased adhesion. In addition, SDF-1
augmented
4
7-dependent adhesion of RPMI 8866 cells
to connecting segment-1 of fibronectin. While pertussis toxin totally
blocked chemotaxis of CD4+ and RPMI 8866 cells to SDF-1
,
enhanced
4
7-dependent adhesion triggered
by this chemokine was partially inhibited, indicating the participation
of G
i-dependent as well as G
i-independent
signaling. Accordingly, we show that SDF-1
induced a rapid and
transient association between its receptor CXCR4 and G
i,
whereas association of pertussis toxin-insensitive G
13
with CXCR4 was slower and of a lesser extent. SDF-1
also activated
the small GTPases RhoA and Rac1, and inhibition of RhoA activation
reduced the up-regulation of
4
7-mediated
lymphocyte adhesion in response to SDF-1
, suggesting that activation
of RhoA could play an important role in the enhanced adhesion. These
data indicate that up-regulation by SDF-1
of lymphocyte adhesion
mediated by
4
7 could contribute to
lymphocyte homing to secondary lymphoid tissues. | Introduction |
|---|
|
|
|---|
4
7 is a cell adhesion
receptor expressed on different T and B lymphocyte subsets that
mediates their attachment to HEV in mucosa-associated lymphoid tissues
by interacting with mucosal vascular addressin mucosal addressin cell
adhesion molecule-1 (MAdCAM-1) (5, 6, 7, 8, 9). MAdCAM-1, a 60-kDa
glycoprotein that belongs to the Ig superfamily, is expressed on HEV in
Peyers patches, mesenteric lymph nodes, and lamina propria venules
within the gut, and its expression represents sites of lymphocyte
extravasation into these intestine-associated lymphoid tissues
(4, 9, 10). Naive T lymphocytes
(CD45RA+ among CD4+) show
relatively homogeneous intermediate levels of
4
7 expression,
whereas memory B and T lymphocytes can be subdivided into
4
7high
and
4
7-
populations (6, 11, 12). Both naive and memory T cells
home efficiently to Peyers patches, but
4
7-
lymphocytes are excluded (12, 13), indicating that
4
7 expression is
associated with homing to intestinal lymphoid tissues.
Apart from mediating cell adhesion to MAdCAM-1,
4
7 can also interact
with the connecting segment-1 region of fibronectin (CS-1/FN)
(14, 15). This interaction might play an important role in
4
7high
lymphocyte homing within lymphoid tissues rather than in recruitment of
lymphocytes from the blood (4). Several amino acids on
both
4 and
7 subunits
that are critical for
4
7-dependent cell
adhesion to MAdCAM-1 and CS-1/FN have recently been identified
(16, 17, 18).
After tethering and rolling of lymphocytes on HEV, they rapidly stick
and arrest, a process involving
4
7/MAdCAM-1
interactions and favored by chemokine-triggered integrin activation
(19). The stromal cell-derived factor-1
(SDF-1
;
CXCL12) is a CXC chemokine that potently attracts lymphocytes
(20, 21, 22) and exerts chemoattractive and activating
functions upon binding to its G protein-coupled receptor CXCR4, which
is expressed on B and T lymphocytes, including
CD4+ and CD8+ cells
(23, 24, 25, 26). In addition, CXCR4 acts as a coreceptor for
T-tropic HIV, and SDF-1
inhibits T tropic HIV infection (23, 25).
Previous studies have shown that SDF-1
can modulate the adhesive
activity of the VLA-4 integrin on CD34+ human
bone marrow hemopoietic progenitors, myeloma cells, and T lymphocytes
(27, 28, 29, 30). SDF-1
is constitutively expressed on many
tissues, including secondary lymphoid tissues (20, 31),
and is therefore a potential candidate to contribute to lymphocyte
homing during recirculation. In the present work we have investigated
whether
4
7-dependent
lymphocyte adhesion to MAdCAM-1 and CS-1/FN can be subjected to
regulation by SDF-1
. Modulation of this adhesion could contribute to
lymphocyte homing to mucosa-associated lymphoid tissue.
| Materials and Methods |
|---|
|
|
|---|
The human B lymphoblastoid cell line RPMI 8866 was cultured in
RPMI 1640 medium (BioWhittaker, Verviers, Belgium) supplemented with
10% FBS (BioWhittaker) and antibiotics (complete medium). The
Chinese hamster ovary (CHO)-MAdCAM-1 transfectants were maintained in
-MEM (BioWhittaker) supplemented with 10% FBS and
containing 0.8 mg/ml G418 (Calbiochem, San Diego, CA). Human PBMC were
isolated from buffy coats using a Ficoll density gradient
(Biochrom, Berlin, Germany). After attachment to plastic for 1.5 h
at 37°C in complete medium, nonadhered cells were recovered, and
CD4+ T lymphocytes were purified with the CD4
Positive Isolation kit (Dynal Biotech, Oslo, Norway). Purity was >99%
for each sample, as analyzed by flow cytometry (EPICS XL; Coulter,
Hialeah, FL). The mAbs used in this study included
anti-
1 Lia 1/2.1, anti-CD4 T4,
anti-CD45RA RP 2/2.1, P3X63 (all gifts from Dr. F.
Sánchez-Madrid, Hospital de la Princesa, Madrid, Spain),
anti-
4
7 Act-1
(32), anti-CD45RO (Caltag Laboratories, Burlingame,
CA), anti-CXCR4 44.717.111 (R&D Systems, London, U.K.), and
CXCR4-01 (33). Anti-G
i polyclonal
Ab was purchased from Santa Cruz Biotechnology (Santa Cruz, CA), and
anti-G
13 was a gift from Dr. P. C.
Sternweis (University of Texas, Dallas, TX).
Static adhesion assays
The generation of a soluble human MAdCAM-1-Ig fusion protein
(sMAdCAM-1-IgG) has been previously described
(18). The FN-H89 fragment of fibronectin, which contains
the CS-1 site and lacks the RGD central binding domain, was generated
as previously reported (34). Cells were labeled for 20 min
at 37°C with the fluorescent dye,
2',7'-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein acetoxymethyl
ester (BCECF-AM) (Molecular Probes, Leiden, The Netherlands),
washed, resuspended in adhesion medium (RPMI/0.5% BSA), and
preincubated with or without inhibitors or Abs. In those experiments in
which soluble recombinant human (rh)SDF-1
(R&D Systems) was used,
cells were incubated with the chemokine and added (6 x
104 RPMI 8866 or 105
CD4+) in triplicate to 96-well dishes
(High-binding; Costar, Cambridge, MA) coated with 5 µg/ml FN-H89 as
previously described (35) or containing a CHO-MAdCAM-1
monolayer. For adhesions to FN-H89, plates were spun for 15 s to
place cells in contact with the ligand and allowed to adhere for 5 min
at 37°C. For adhesions to CHO-MAdCAM-1, cells were incubated for 10
min at 37°C with no previous centrifugation. Unbound cells were
removed by three washes with RPMI 1640 medium. When rhSDF-1
was
coimmobilized with ligands, the chemokine was prepared at 0.5 µg/ml
in sodium bicarbonate buffer (0.1 M, pH 8.8) for FN-H89 (5 µg/ml) or
in carbonate buffer (pH 9.5) for sMAdCAM-1-Ig (300 ng/well) adhesions.
The mixtures (50 µl/well) were coated on 96-well dishes for 2 h
at 37°C, and wells were finally blocked with 0.5% BSA in the same
corresponding buffers. For sMAdCAM-1-Ig, cells were allowed to settle
for 5 min at 4°C, and then adhesion was conducted for 30 min at
37°C, followed by three gentle washes with RPMI 1640. Bound cells
were lysed with 1% SDS in PBS, and the extent of adhesion was
quantified using a fluorescence analyzer (POLARstar Galaxy; BMG
Labtechnologies, Offenburg, Germany). Inhibitors included cytochalasin
D and pertussis toxin (PTX; Calbiochem). Recombinant C3 transferase was
expressed and purified as previously described (36).
Flow chamber adhesion assays
Several 15-mm2 areas on petri dishes were
coated for 2 h at 37°C with 15 µl PBS containing sMAdCAM-1-IgG
alone (4 µg/ml), sMAdCAM-1-IgG with SDF-1
(2 µg/ml), or SDF-1
or PBS alone. The coated spots were washed with PBS and blocked for
1 h at 37°C with FCS. Petri dishes were incorporated as the
lower wall of a parallel flow chamber (IQUUM, Boston, MA) and mounted
on an inverted microscope (IX-70, Olympus, Tokyo, Japan)
connected to a CCD camera (Cohu, San Diego, CA).
CD4+ or RPMI 8866 cells
(106/ml) preincubated in the absence or the
presence of PTX and/or
anti-
4
7 Act-1 Ab
(10 µg/ml) were infused at 37°C for 2 min at a flow rate of 1
dyne/cm2. Flow was then stopped, and cells were
allowed to settle for different times. Total cells from different
fields were counted before flow was restored (0.52
dyne/cm2), and cells remaining tightly bound for
>3 min were counted. Data are presented as the percentage of cells
remaining bound compared with total cells in each field before
reestablishing the flow.
Actin polymerization and chemotactic assays
To determine the content of polymerized actin (F-actin),
105 cells per condition were permeabilized,
fixed, and stained in a single step by addition of a 2x solution
containing 0.5 mg/ml L-
-lysophosphatidyl-choline
(Sigma-Aldrich, St. Louis, MO), 8% formaldehyde, and 4 U/ml
FITC-phalloidin (Molecular Probes, Eugene, OR). Cells were incubated at
22°C for 10 min, washed with PBS, and subjected to flow cytometry.
For chemotactic assays, RPMI 8866 (2 x 105)
or CD4+ cells (3 x
105) in 100 µl adhesion medium were placed in
the upper chamber of a Transwell (5-µm pore size; Costar). Then 600
µl adhesion medium with or without rhSDF-1
(200 ng/ml) was added
to the lower chamber, and cells were allowed to migrate for 3 h at
37°C. Viable migrated cells were counted in a flow cytometer,
analyzing each sample in the same predetermined time and flow
conditions. Where indicated, cells were treated with 500 ng/ml PTX for
2 h at 37°C.
GTPase activity assays
We followed essentially the method previously reported
(37). The GST-C21 and GST-PAK-CD fusion proteins were
generated as previously described (38). To determine the
effect of SDF-1
on RhoA and Rac1 activation, cells were treated with
or without 150 ng/ml rhSDF-1
, washed in ice-cold PBS, and incubated
for 15 min at 4°C in lysis buffer (37). For RhoA and
Rac1 activation upon
4
7/sMAdCAM-1-Ig
interaction, we performed soluble binding assays of RPMI 8866 cells
with sMAdCAM-1-Ig (3040 µg/ml, 30 min at 23°C), following the
method previously described (16). Cells were then
collected, washed, and lysed as described above. Lysates were
centrifuged, 15 µl was kept for total lysate samples, and the
remaining 185 µl was mixed with fusion proteins precoupled to
glutathione-agarose beads. The beads and proteins bound to the fusion
protein were washed in an excess of lysis buffer, eluted in Laemmli
sample buffer, and analyzed for bound Rac1 or RhoA by Western blotting
using mAbs against human Rac1 (BD PharMingen/Transduction Laboratories,
San Diego, CA) or RhoA (Santa Cruz Biotechnology).
Immunoprecipitation, SDS-PAGE, and Western blot
After SDF-1
stimulation, untreated or PTX-treated cells were
solubilized (20 mM triethanolamine (pH 8), 300 mM NaCl, 2 mM EDTA, 20%
glycerol, and 1% digitonin, with 10 µM sodium orthovanadate, 10
µg/ml leupeptin, and 10 µg/ml aprotinin). Following centrifugation,
lysates were immunoprecipitated as previously described
(39) using CXCR4-01 Ab. Precipitates or protein extracts
were separated in SDS-PAGE and transferred to nitrocellulose membranes.
Western blot analysis was performed as previously reported
(39), using 5% nonfatty dry milk in TBS as the blocking
agent. Protein loading was controlled using a protein detection kit
(Pierce, Rockford, IL) as well as by reprobing the membrane with the
immunoprecipitating Ab.
Statistical analysis
The results are expressed as the mean ± SD of data obtained from three or more experiments performed in triplicate unless otherwise stated. Statistical significance was determined using two-tailed Students t test.
| Results |
|---|
|
|
|---|
up-regulates
4
7-mediated
lymphocyte adhesion to MAdCAM-1
Expression of CXCR4 on human CD4+ T
lymphocytes and that on the
4
7+
4
1-
B lymphoblastoid cell line RPMI 8866 have been previously described
(24, 26). CXCR4 expression conveyed a chemotactic response
of CD4+ and RPMI 8866 cells to SDF-1
that was
abolished by PTX, indicating the participation of heterotrimeric G
proteins of the Gi family (Fig. 1
A). In addition, SDF-1
triggered a rapid and transient increase in F-actin polymerization in
both cell types (Fig. 1
B). These results indicated that
CXCR4 on CD4+ and RPMI 8866 cells mediated
cellular responses leading to cell motility and changes in the
organization of actin cytoskeleton.
|
could influence lymphocyte adhesion to
MAdCAM-1, we used CHO transfectant cells expressing MAdCAM-1 on their
membranes as well as sMAdCAM-1-IgG. Soluble SDF-1
transiently
up-regulated the adhesion of human CD4+ and RPMI
8866 cells to CHO-MAdCAM-1 transfectants, whereas the
anti-
4
7 Ab Act-1
partially inhibited the increased adhesion (Fig. 2
4
7 was involved in
SDF-1
-triggered up-regulation of adhesion and suggesting that
additional adhesion pathways were also activated by SDF-1
.
Preincubation of cells with soluble SDF-1
(from 1 to 20 min) did not
significantly influence their subsequent adhesion to sMAdCAM-1-IgG
(data not shown). As SDF-1
can be immobilized and displayed on
endothelium (27, 30), we investigated whether SDF-1
coimmobilized with sMAdCAM-1-IgG could trigger a more effective
response in lymphocyte adhesion to this
4
7 ligand. A robust
up-regulation of CD4+ and RPMI 8866 cell adhesion
was obtained when both SDF-1
and sMAdCAM-1-IgG were immobilized on
the same well, which was completely blocked by Act-1 Ab (Fig. 3
-enhanced adhesion was totally mediated by
4
7. The extent of
increased adhesion was larger when basal adhesion to MAdCAM-1 alone was
low. As a control, wells with SDF-1
alone did not support cell
adhesion. In addition, SDF-1
did not induce
CD4+ or RPMI 8866 cell aggregation (data not
shown), ruling out a possible contribution to the up-regulated
adhesion.
|
|
could convey a resistance to detachment under shear stress by
measuring the extent of cells remaining bound after applying shear
flow. We found that activation with SDF-1
notably augmented the
percentage of CD4+ and RPMI 8866 cells remaining
firmly attached to sMAdCAM-1-IgG after applying wall shear stresses of
0.52 dynes/cm2 (Fig. 3
4
7, and no cells
remained bound to SDF-1
alone or FCS.
Naive and memory CD4+ T cell subpopulations are both
targets for SDF-1
-triggered up-regulation of adhesion to MAdCAM-1
To determine whether SDF-1
was preferentially targeting
naive CD45RA+ or memory
CD45RO+ phenotype cells among human
CD4+ T lymphocytes for increased adhesion
to MAdCAM-1, we compared by FACS analysis cells recovered from adhesion
to MAdCAM-1 alone, MAdCAM-1 coimmobilized with SDF-1
, or the whole
cell population before the adhesion assay. The results showed
that the proportions of CD45RA+ and
CD45RO+ cells were similar inside the
CD4+ cell population attached to MAdCAM-1
immobilized with or without SDF-1
. However, a minor, but consistent,
decrease in naive CD45RA+ cells and a concomitant
slight increase in memory cells in the population recovered from
adhesions to coimmobilized SDF-1
and MAdCAM-1 were detected (Fig. 4
). These data suggest that SDF-1
targets both memory and naive CD4+ T
lymphocytes in the up-regulation of
4
7-mediated adhesion
to MAdCAM-1, with a slight preference for memory
CD45RO+ cells.
|
increases
4
7-mediated
adhesion to CS-1/fibronectin
The CS-1 region of fibronectin represents an additional
binding site for
4
7
(14, 15). We used RPMI 8866 cells to test the effect of
SDF-1
on adhesion to FN-H89, a CS-1-containing fragment of
fibronectin. A short (2-min) incubation of RPMI 8866 cells with soluble
SDF-1
augmented the adhesion to FN-H89, which was blocked by
Act-1, but not by Lia 1/2.1 anti-
1 Ab
(Fig. 5
, left panel). Similar
to sMAdCAM-1-IgG, a substantially higher up-regulation of adhesion of
RPMI 8866 cells was obtained when both FN-H89 and SDF-1
were
coimmobilized in the same well compared with the adhesion to FN-H89
alone (Fig. 5
, right panel). The adhesion was totally
inhibited by Act-1, indicating that
4
7 was mediating this
increased adhesion.
|
-triggered increase in
4
7-mediated cell adhesion
As shown above, chemotaxis of CD4+ and RPMI
8866 cells in response to SDF-1
was abolished by PTX, an agent that
catalyzes the ADP ribosylation of specific G protein
subunits of
the Gi family, preventing receptor-G protein
interactions (40). PTX did not reduce the enhancement of
static adhesion of CD4+ T cells to MAdCAM-1
coimmobilized with SDF-1
when a 30-min adhesion time was used or
when we performed shorter (7.5-min) adhesions after a spin to place
cells in contact with ligands, an assay condition that resulted in
similar basal adhesion levels and up-regulated
CD4+ adhesion (Fig. 6
A, left panel).
Only a small fraction (<20%) of the increased adhesion of RPMI 8866
cells to MAdCAM-1 immobilized with SDF-1
was inhibited by PTX when
adhesion was conducted for 30 min (Fig. 6
A, right
panel). When we shortened the time of adhesion to 2 min after cell
centrifugation, a 4050% inhibition by PTX was obtained. In addition,
the SDF-1
-triggered increase in RPMI 8866 cell adhesion to FN-H89
was only partially reduced by PTX both when soluble SDF-1
was used
and when it was coimmobilized with FN-H89 (Fig. 6
B).
|
, the increase in adhesion strengthening
measured as cells remaining attached under flow was reduced by about
half compared with the adhesion of cells incubated without PTX (Fig. 7
was increased for
>10 min, no effect of PTX was detected (data not shown). PTX also
partially reduced (3050%) the percentage of RPMI 8866 cells
remaining bound to MAdCAM-1 immobilized with SDF-1
under shear
stress after a 3-min adhesion (Fig. 7
4
7 in these
attachments. Together, these results suggest that
G
i-dependent as well as
G
i-independent signaling are involved in
SDF-1
-triggered enhancement of
4
7-mediated cell
adhesion.
|
4
7-mediated cell adhesion by SDF-1
Small GTPases of the Rho family, like RhoA and Rac1, are
key regulators of the organization of actin cytoskeleton
(41). Upstream events leading to the exchange of GDP for
GTP bound to Rho GTPases activate them so they can then interact with
downstream targets to produce different biological responses. We used
RPMI 8866 cells to study whether SDF-1
influences the activation of
RhoA and Rac1, by performing pull-down assays with GST fusion proteins
containing domains derived from Rho GTPase targets. SDF-1
rapidly (1
min) and substantially increased the amount of active RhoA and Rac1
from basal levels, as detected with the GST-C21 and GST-PAK-CD fusion
proteins, respectively, and this activation was still detected,
although at lower levels, after 15-min incubations (Fig. 8
A). To obtain some insight
into a potential participation of RhoA activation in the
SDF-1
-triggered increase in RPMI 8866 adhesion, we used C3
transferase, an enzyme that specifically ADP-ribosylates and inhibits
Rho activation (42). C3 reduced to approximately half the
increase in RPMI 8866 cell adhesion to MAdCAM-1 immobilized with
SDF-1
, whereas it totally blocked their up-regulated adhesion to
FN-H89 (Fig. 8
B), suggesting that activation of RhoA could
be involved in the increased adhesion. Cytochalasin D, an agent that
disrupts actin filaments, blocked the up-regulation of F-actin
polymerization triggered by SDF-1
on CD4+ and
RPMI 8866 cells (data not shown). Preincubation with cytochalasin D at
concentrations of up to 5 µg/ml substantially inhibited the enhanced
adhesion of CD4+ T lymphocytes without affecting
their basal adhesion to MAdCAM-1 alone (Fig. 8
C). This same
concentration partially inhibited (30%) the increase in adhesion of
RPMI 8866 cells, and we did not use higher concentrations because basal
adhesion was affected. These results suggest that the actin
cytoskeleton plays a relevant role in SDF-1
-induced enhancement of
cell adhesion to MAdCAM-1 mediated by
4
7.
|
4
7/sMAdCAM-1-IgG
interaction itself could trigger additional activation of RhoA and/or
Rac1. In a soluble binding assay (16), RPMI 8866 cells
bound sMAdCAM-1-IgG, as detected by flow cytometry using a
PE-conjugated anti-human IgG Fc-specific Ab, and the Act-1 Ab
abolished the binding (data not shown). Pull-down assays
performed with GST-PAK-CD and GST-C21 fusion proteins using RPMI 8866
cells incubated with sMAdCAM-1-IgG showed a modest (2-fold) increase in
Rac1 activation that was inhibited by blocking
4
7/sMAdCAM-1-IgG
binding with Act-1, whereas no significant alterations in RhoA
activation were detected (Fig. 9
|
induces association of CXCR4 with heterotrimeric
G
i and G
13 proteins
Western blot analysis of RPMI 8866 lysates using Abs to several
heterotrimeric G
proteins revealed significant expression of
G
i as well as PTX-resistant
G
13 and G
q/11 (data
not shown). To characterize G protein association with CXCR4 upon
SDF-1
stimulation, we incubated RPMI 8866 cells with SDF-1
, and
cell lysates were immunoprecipitated with anti-CXCR4 Abs, followed
by Western blotting using anti-G
i and
G
13 Abs. The results showed that
G
i rapidly and transiently interacted with
CXCR4 upon SDF-1
activation, with a maximum association detected
between 1 and 3 min (Fig. 10
).
G
13 also associated with CXCR4 after SDF-1
stimulation, but with slower kinetics (maximum at
5 min) and to a
lesser extent compared with CXCR4/G
i
association, as longer gel exposures were needed to sufficiently detect
G
13. G
i was barely
detected associated with CXCR4 when these experiments were conducted
with PTX-treated cells. Interestingly, higher amounts of
G
13 were found associated with CXCR4, and time
kinetics revealed a faster CXCR4/G
13
interaction compared with nontreated RPMI 8866 cells (Fig. 10
). These
data indicate that G
i and
G
13 are involved in SDF-1
-induced RPMI 8866
cell activation.
|
| Discussion |
|---|
|
|
|---|
in
4
7-mediated
lymphocyte adhesion using human CD4+ T
lymphocytes and the lymphoblastoid cell line RPMI 8866 as models. The
results indicated that SDF-1
strongly up-regulated their
4
7-dependent adhesion
to sMAdCAM-1-Ig as well as their adhesion to membrane-bound MAdCAM-1
expressed on CHO transfectants. In addition, SDF-1
increased
4
7-mediated RPMI 8866
cell attachment to the CS-1-containing FN-H89 fragment of
fibronectin.
Enhancement of cell adhesion to sMAdCAM-1-Ig was detected by
coimmobilizing SDF-1
with this
4
7 ligand and was
achieved in both static adhesion assays as well as under shear stress
by measuring the resistance to cell detachment after applying shear
flow. The data suggested that the effect of SDF-1
on
4
7-mediated adhesion
to sMAdCAM-1 probably involved strengthened cell adhesion to this
ligand, leading to firm attachment. The rational for using immobilized
SDF-1
was based on the observation that it can be found attached to
bone marrow endothelium (27) and can be displayed on the
surface of HUVEC (30). Although we do not have
experimental evidence, it is possible that up-regulation of
4
7-mediated
lymphocyte adhesion to CHO-MAdCAM-1 induced by soluble SDF-1
might
be due to its attachment to the surface of CHO-MAdCAM-1 monolayers,
which could stabilize its binding to CXCR4 on lymphocytes.
The increase in
4
7-mediated
CD4+ cell adhesion to MAdCAM-1 by SDF-1
targeted both naive CD45RA+ and memory
CD45RO+ subset cells. Memory cells express lower
levels of CXCR4 than naive cells (24, 26, 43), but they
respond to SDF-1
with equal or even slightly higher efficacy in
up-regulation of adhesion to MAdCAM-1. This could be due to the fact
that
4
7+
memory cells express higher levels of
4
7 than naive cells
(11, 12, 44), which might allow them to attach with more
strength to MAdCAM-1, enhancing the likelihood of SDF-1
/CXCR4
binding. These results suggest that the pattern of
4
7 expression among
memory and naive subset cells and the subsequent
4
7/MAdCAM-1
interaction might be dominant over the signaling originated upon
SDF-1
/CXCR4 binding, which triggers the increase in cell
adhesion.
Chemotaxis of CD4+ and RPMI 8866 cells in
response to SDF-1
was abolished by PTX, indicating an involvement of
heterotrimeric G proteins of the Gi family.
However, their up-regulated adhesion to sMAdCAM-1-Ig triggered by
SDF-1
was only partially affected by PTX when tested on resistance
to cell detachment under shear flow or in static adhesion assays. These
data indicate that G
i-dependent signaling is
involved in the subsequent increase in
4
7 adhesive activity
and suggest that additional, G
i-independent
signaling plays a role in SDF-1
-triggered enhanced adhesion.
Reinforcing the involvement of G
i in the
modulation of
4
7-mediated cell
adhesion, we detected a rapid and transient association with CXCR4 in
RPMI 8866 cells incubated with SDF-1
.
PTX-insensitive heterotrimeric G proteins include members of the
G12 and Gq families
(45). We show in this work that in RPMI 8866 cells
SDF-1
stimulated the interaction of CXCR4 with
G
13, a G
12 family
member, although to a lesser degree and with slower kinetics than
CXCR4/G
i association. Interestingly, the
amount of CXCR4-associated G
13 upon SDF-1
stimulation was notably enhanced in cells treated with PTX, and, as
expected, there was a large reduction in
G
i/CXCR4 interaction, raising the possibility
that both G
i and G
13
interact with the same or closely located binding sites on CXCR4 and
that G
13/CXCR4 association increases after
G
i blockade. Alternatively,
G
i might influence
G
13 binding at a different site on CXCR4,
which again could be increased upon inhibition of
G
i binding. Therefore, the PTX-resistant
increase in cell adhesion to MAdCAM-1 in response to SDF-1
could be
the result of enhanced G
13 activation and its
involvement in this adhesion. A known downstream effector target of
G
13 is p115 RhoGEF (46), a
Rho-activating guanine nucleotide exchange factor, and it has been
reported that activation of G
13 mimicked the
effects of activated forms of Rho on stress fiber formation that was
inhibited by C3 (47, 48). In the present work we show that
SDF-1
activated RhoA and Rac1 on RPMI 8866 cells, and inhibition of
RhoA activation by C3 considerably reduced the up-regulation of
4
7-dependent
adhesion, suggesting that activation of RhoA represents an important
point in the signals leading to increased adhesion. Previous work
reported that expression of activated forms of RhoA caused an increase
in
4
7-dependent T
lymphoma adhesion to MAdCAM-1 (49), an observation in the
same line as the present findings on the proposed role of RhoA
activation by SDF-1
in the up-regulation of
4
7-mediated cell
adhesion.
Additionally, we found that blockade of SDF-1
-triggered F-actin
polymerization in CD4+ and RPMI 8866 cells by
cytochalasin D interfered with their response by increased adhesion to
MAdCAM-1. As RhoA and Rac1 are key regulators of actin cytoskeleton
organization, and their activity influences cell motility
(41), it is possible that a functional link exists between
SDF-1
-induced activation of RhoA and Rac1 and reorganization of
actin cytoskeleton, which could be associated with the modulation of
4
7-dependent cell
adhesion.
Together these data indicate that
G
i-dependent signaling plays an important role
in the up-regulation of
4
7-dependent cell
adhesion to MAdCAM-1 in response to SDF-1
and raises the possibility
that activation of G
13 could also contribute
to the up-regulated adhesion. The kinetics of CXCR4 association
with G
i and G
13
suggest that the faster signaling wave leading to increased adhesion
originates from G
i activation. Activation of
G
i results in inhibition of adenylyl cyclases
(45), and it has been suggested that changes in cAMP
levels due to modulation of adenylyl cyclase activity by
chemoattractants could represent an important point in the regulation
of integrin-dependent leukocyte adhesion (50). Therefore,
alterations in cAMP levels by
G
i-activated downstream signaling could
also be involved in the SDF-1
-triggered increase in
4
7 adhesive activity.
Several studies focused on
4 integrin-mediated
adhesion have also determined that Gi-dependent
signaling is needed to activate this adhesion, based on PTX inhibition
(19, 30, 51, 52). A second signaling wave,
G
I independent and potentially arising from
G
13, could activate downstream effectors, such
as RhoA and perhaps also Rac1, which could result in an additional
increase in and/or maintenance of
4
7-mediated adhesion,
favoring lymphocyte adhesion strengthening and resistance to detachment
under shear stress. Studies addressing
G
i and G
13
involvement in modulation of
4
7-dependent
lymphocyte adhesion using mutant forms of these G proteins will be of
key importance to characterize their participation in this process. In
addition, it has been recently reported that SDF-1
activates
Gq, which mediates LFA-1 activation during in
vivo migration of T cell hybridoma cells (53). A possible
activation of Gq by SDF-1
in lymphocytes could
represent an additional candidate mechanism contributing to the
increase in
4
7
adhesive activity.
Reorganization of actin cytoskeleton induced by SDF-1
might cluster
4
7 on the cell
membrane, which might influence the avidity for its ligands. In this
regard, it has been proposed that integrin clustering plays important
roles in changes in the avidity of
4
1-mediated adhesion
(30, 54). Additionally, affinity modulation of
4
7-dependent adhesion
by SDF-1
is not excluded, as this chemokine can influence
4
1 affinity for
VCAM-1 (55). We also show here that
4
7/MAdCAM-1
interaction activates Rac1, which could contribute to the maintenance
of enhanced lymphocyte adhesion and resistance to detachment.
The interaction of
4
7
with MAdCAM-1 on Peyers patches and lamina propria HEV represents a
key adhesion pathway in lymphocyte homing during recirculation
(4). SDF-1
is expressed on most tissues, including
secondary lymphoid tissues such as Peyers patches (31),
and it has been proposed to be involved in lymphocyte recirculation
(20, 31). SDF-1
displayed by HEV could bind to CXCR4 on
lymphocytes, and our present data indicate that a functional
consequence of this interaction is the up-regulation of
4
7 adhesive activity,
which might lead to lymphocyte adhesion strengthening to MAdCAM-1,
representing a mechanism contributing to lymphocyte homing to secondary
lymphoid tissues.
The CC chemokine secondary lymphoid tissue chemokine (SLC)
(CXCL21) has also been reported to up-regulate
4
7-dependent adhesion
of human PBL and T cell lines to MAdCAM-1 in both static and flow
chamber adhesion assays (51). It was found that SLC had a
greater effect on naive than on memory CD4+ T
cells, consistent with a preferential role of this chemokine for the
homing of naive T cells, which has been further demonstrated with the
use of plt mice that lack SLC expression
(56, 57, 58). Both SDF-1
and SLC are probably involved in
lymphocyte homing to secondary lymphoid tissues from the blood, but the
present results together with SLC modulation of
4
7-dependent
lymphocyte adhesion suggest that SDF-1
might have a lesser role than
SLC in defining the specificity of lymphocyte subset targeting.
4
7 binding to CS-1/FN
might be important in gut-homing lymphocyte-matrix interactions within
lymphoid tissues (4). In addition,
4
7/FN interaction has
been suggested to play important roles in lymphoma dissemination
(59). Consequently, modulation of this adhesion by
SDF-1
could contribute to lymphocyte trafficking in normal immune
surveillance as well as in lymphoma invasion.
Further research directed at characterizing the mechanisms underlying
chemokine-triggered modulation of
4
7-dependent
lymphocyte adhesion, including the study of G
i
and G
13 involvement, is required for a better
characterization of the molecular events implicated in lymphocyte
homing during recirculation.
| Acknowledgments |
|---|
| Footnotes |
|---|
2 Current address: Department of Hematology, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029. ![]()
3 Address correspondence and reprint requests to Dr. Joaquin Teixidó, Department of Immunology, Centro de Investigaciones Biológicas, Velázquez 144, 28006 Madrid, Spain. E-mail address: joaquint{at}cib.csic.es ![]()
4 Abbreviations used in this paper: HEV, high endothelial venule; CS-1/FN, connecting segment-1 of fibronectin; F-actin, polymerized actin; PTX, pertussis toxin; SDF-1
, stromal cell-derived factor-1
; rh, recombinant human; MAdCAM-1, mucosal addressin cell adhesion molecule-1; sMAdCAM-1-IgG, soluble human MAdCAM-1-Ig fusion protein; CHO, Chinese hamster ovary; BCECF-AM, 2',7'-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein acetoxymethyl ester; SLC, secondary lymphoid tissue chemokine. ![]()
Received for publication July 12, 2001. Accepted for publication March 5, 2002.
| References |
|---|
|
|
|---|
chain homologous to human VLA-4
. Cell 56:37.[Medline]
subunit (
7) identified in leukocytes. J. Biol. Chem. 266:11009.
7 subunit. J. Biol. Chem. 267:7352.
p(
7): a functional role in Peyers patch-specific lymphocyte homing. Proc. Natl. Acad. Sci. USA 89:8254.
4
7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 74:185.[Medline]
4
7 on a subset of human CD4+ memory T cells with hallmarks of gut-tropism. J. Immunol. 151:717.[Abstract]
4
1 (VLA-4) and
4
7 on the human B cell line JY. J. Biol. Chem. 267:8366.
4
7/
4
P in lymphocyte adherence to fibronectin and VCAM-1 and homotypic cell clustering. J. Cell Biol. 117:179.
4 integrin subunit Tyr187 has a key role in
4
7-dependent cell adhesion. J. Biol. Chem. 275:7052.
and
chains in ligand recognition by
7 integrins. J. Biol. Chem. 275:25652.
7 subunit. J. Immunol. 159:1497.[Abstract]
4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 80:413.[Medline]